Using mouse genomics to understand idiopathic interstitial fibrosis
David M Brass1, John Tomfohr, Ivana V Yang
1Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. brassd@niehs.nih.gov
Proceedings of the American Thoracic Society
|January 5, 2007
Summary
Idiopathic interstitial fibrosis (IIF) research uses mouse models to study lung scarring. Genetic and genomic tools help identify genes involved in this debilitating fibrotic lung disease.
Area of Science:
- Pulmonary Medicine
- Pathogenesis Research
- Fibrotic Lung Disease
Background:
- Idiopathic interstitial pneumonia (IIP) encompasses lung disorders marked by fibrosis and inflammation.
- Idiopathic interstitial fibrosis (IIF) is a severe IIP subtype, often diagnosed late.
- Current understanding of IIF pathogenesis relies on clinical observations and the need for early-stage animal models.
Purpose of the Study:
- To review the use of mouse genetic and genomic tools in IIF models.
- To explore agnostic approaches for identifying genes in IIF's fibroproliferative component.
Main Methods:
- Application of mouse genetic tools to animal models of lung fibrosis.
- Genomic analysis to identify genes associated with fibroproliferation.
- Review of existing literature on IIF pathogenesis and modeling.
Main Results:
- Mouse models, while not perfectly mimicking human IIF, exhibit lung scarring relevant to disease study.
- Genetic and genomic approaches offer powerful means to dissect the biological processes underlying lung fibrosis.
- Emerging agnostic strategies show promise in discovering novel genes involved in IIF.
Conclusions:
- Mouse models are valuable for investigating the mechanisms of lung scarring in IIF.
- Genetic and genomic tools are crucial for advancing the understanding of IIF pathogenesis.
- Further research using these tools can identify therapeutic targets for fibroproliferative lung diseases.


